Pw. Lowry et al., CELLULAR IMMUNE-RESPONSES TO 4 DOSES OF PERCUTANEOUS BACILLE CALMETTE-GUERIN IN HEALTHY-ADULTS, The Journal of infectious diseases, 178(1), 1998, pp. 138-146
To explore the hypothesis that low-dose immunization might induce pref
erential Th1 cell immunity, 76 adults were vaccinated with one of four
doses of bacille Calmette-Guerin (BCG):The doses contained very low (
1.6 X 10(5) cfu), low (3.2 x 10(6) cfu), standard (1.6 x 10(8) cfu), o
r high (3.2 x 10(8) cfu) levels of BCG. Delayed-type hypersensitivity
responses occurred 8 weeks after vaccination in 10% of persons given v
ery low or low doses of BCG, compared with 95% and 100% of persons giv
en standard or high doses, respectively. Lymphoproliferative responses
, which were increased only for high-dose vaccinees, peaked 2 weeks af
ter vaccination and were directed chiefly against Mycobacterium tuberc
ulosis-secreted proteins, particularly the antigen 85 complex. Signifi
cant increases in mycobacteria-specific interferon-gamma expression we
re present 16 weeks after vaccination only for persons given standard
or high doses of BCG. Percutaneous BCG appears capable of inducing a t
emporary Th1-like immune response, but standard or higher dosages are
required.